OakChart

KORU Medical Systems Inc

KRMDHealthcare·Medical Instruments & Supplies·USA·Micro·NASD·Nov 11 • 3:59 PM ET

3.89+0.73 (23.10%)
2026-11-12 05:10 CET
Market cap
179.61 USD m
Revenue, TTM
46.27 USD m
Net income, TTM
-0.82 USD m
Free cash flow, TTM
-0.39 USD m
EPS diluted, TTM
-0.02
P/E
-
Compare

Price

KRMD against its 20, 50 and 200-day averages
2050200beat
3.003.504.004.50538K1.1MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26KRMDclose 3.8920-day 3.1550-day 3.13200-day 3.923.8952w low

41.1% under the 52-week high of 6.61 on 24 Dec 2025. 52-week low 2.86 on 1 Oct 2026. Last 15 sessions, 35.8% high to low

Volume 3.26× normal · the line is the 50-bar volume average

Profile

KRMD
52-week range, 27% of the way up
2.866.61

KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. Its product portfolio includes FREEDOM60, FreedomEdge syringe drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets. The company was founded by Andrew I. Sealfon and Adrian W. Zorgniotti on March 24, 1980 and is headquartered in Mahwah, NJ.

IndexRUT
Employees73
IPOApr 05, 1994
Beta0.51
ATR, 14d0.22
Rel volume3.26
Short float2.00%
Insider own6.76%
Inst own55.00%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap179.60M
Enterprise Value175.74M
Income-0.82M
Sales46.27M
Book/sh0.42
Cash/sh0.16
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees73
IPOApr 05, 1994

Ratios

P/E-
Forward P/E151.66
PEG-
P/S3.88
P/B9.30
P/C24.40
P/FCF-
EV/EBITDA798.84
EV/Sales3.80
Quick Ratio2.27
Current Ratio2.97
Debt/Eq0.18
LT Debt/Eq0.13
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.02
EPS next Y0.03
EPS next Q-0.00
EPS this Y64.04%
EPS next Y218.89%
EPS next 5Y-
EPS past 3/5Y33.31% -14.59%
Sales past 3/5Y13.81% 11.21%
EPS Y/Y TTM78.07%
Sales Y/Y TTM18.43%
EPS Q/Q127.98%
Sales Q/Q11.19%
EarningsNov 10 AMC
EPS/Sales Surpr.100.00% 2.12%

Ownership

Insider Own6.76%
Insider Trans2.00%
Inst Own55.00%
Inst Trans0.12%
ROA-2.95%
ROE-4.59%
ROIC-3.74%
Gross Margin61.90%
Oper. Margin-1.24%
Profit Margin-1.78%
SMA2023.50%
SMA5024.17%
SMA200-0.84%
Trades-

Technical

Shs Outstand46.38M
Shs Float43.05M
Short Float2.00%
Short Ratio3.87
Short Interest0.86M
52W High6.61 -41.13%
52W Low2.86 36.01%
Volatility10.41% 6.28%
ATR (14)0.22
RSI (14)71.45
Beta0.51
Rel Volume3.26
Avg Volume222.66K
Volume725,790

Performance

Perf Week18.96%
Perf Month29.67%
Perf Quarter16.99%
Perf Half Y1.04%
Perf YTD-33.05%
Perf Year4.29%
Perf 3Y81.78%
Perf 5Y10.20%
Perf 10Y784.29%
Recom1.50
Target Price6.12
Prev Close3.16
Price3.89
Change %23.10%

Analyst ratings

latest 10 of 11
DateActionAnalystRating changeTargetImplied
Feb 14, 2025DowngradePPiper SandlerOverweight → Neutral$4.50+15.7%
Jul 25, 2024ResumedRB. Riley SecuritiesBuy$4+2.8%
Sep 07, 2023InitiatedLLake StreetBuy$4+2.8%
Sep 07, 2023InitiatedRB. Riley SecuritiesBuy$4.50+15.7%
Nov 10, 2022UpgradePPiper SandlerNeutral → Overweight$3 → $3.50-10.0%
Nov 10, 2022UpgradeCCanaccord GenuityHold → Buy$3 → $4+2.8%
Jan 26, 2021DowngradePPiper SandlerOverweight → Neutral$9 → $4.50+15.7%
Jan 26, 2021DowngradeCCanaccord GenuityBuy → Hold$5+28.5%
Aug 10, 2020InitiatedHH.C. WainwrightBuy$16+311.3%
Jul 16, 2020InitiatedCCanaccord GenuityBuy$13+234.2%

Peers

Mkt cap
TickerCompanyMkt cap
INFUInfuSystem Holdings Inc302.10M
ICUIICU Medical Inc4.46B
EMBCEmbecta Corp369.99M
WSTWest Pharmaceutical Services Inc28.76B
MLSSMilestone Scientific Inc28.07M
RVPRetractable Technologies Inc16.60M
TNDMTandem Diabetes Care Inc1.31B
UTMDUtah Medical Products Inc208.06M
PODDInsulet Corp10.41B
ELMDElectromed Inc206.84M

Insider trading

latest 14 of 15
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
KALBERMATTEN ADAM RChief Commercial OfficerSep 08 '26Buy3.1632,000101,120394,017Sep 09 04:32 PM
KALBERMATTEN ADAM RChief Commercial OfficerJul 28 '26Option Exercise0.0075,0000387,500Aug 06 04:11 PM
KALBERMATTEN ADAM ROfficerAug 03 '26Proposed Sale4.2625,483108,629Aug 03 05:18 PM
KALBERMATTEN ADAM RPresident-Chief Commercial OffJun 11 '26Buy3.9412,50049,275312,500Jun 15 04:34 PM
Schiller EricChief Technology OfficerMay 18 '26Buy3.915,00019,5625,000May 20 04:41 PM
Tharby Linda MChief Executive OfficerMay 15 '26Buy3.901,1914,645620,622May 20 04:02 PM
Tharby Linda MChief Executive OfficerMay 14 '26Option Exercise0.0013,9770626,757May 19 05:08 PM
Pazdan ChristopherChief Operating OfficerMay 14 '26Option Exercise0.005,3270310,458May 18 04:39 PM
Pazdan ChristopherChief Operating OfficerMay 14 '26Buy3.885,00019,400305,131May 18 04:35 PM
Adams Thomas EdwardChief Financial OfficerMay 14 '26Option Exercise0.008,1930316,340May 18 04:33 PM
Adams Thomas EdwardChief Financial OfficerMay 14 '26Buy3.865,50021,248308,147May 18 04:31 PM
Tharby Linda MOfficerMay 14 '26Proposed Sale3.957,32628,915May 14 05:01 PM
Pazdan ChristopherChief Operating OfficerMar 16 '26Option Exercise0.005,06405,064Mar 18 04:47 PM
Adams Thomas EdwardChief Financial OfficerMar 16 '26Option Exercise0.005,40405,404Mar 18 04:45 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
VXFVanguard Extended Market Index ETFAUM: 30.47B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
IWCiShares Micro-Cap ETFAUM: 1.22B
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETFAUM: 1.06B
VTWGVanguard Russell 2000 Growth Index ETFAUM: 1.41B
RSSLGlobal X Russell 2000 ETFAUM: 1.43B
OMFSInvesco Russell 2000 Dynamic Multifactor ETFAUM: 263.85M

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-100.000-0.0170.00511.5711.334
2026Q22026-08-050.010-0.0180.00512.0511.625
2026Q12026-05-06-0.020-0.020-0.01711.7611.285
2025Q42026-03-12-0.010-0.020-0.01110.9010.825
2025Q32025-11-12-0.020-0.024-0.01710.409.665
2025Q22025-08-060.010-0.023-0.00510.199.464
2025Q12025-05-070.000-0.030-0.0259.648.865
2024Q42025-03-12-0.030-0.028-0.0348.848.895
2024Q32024-11-13-0.030-0.039-0.0358.187.675
2024Q22024-08-07-0.010-0.043-0.0228.437.575
2024Q12024-05-01-0.040-0.038-0.0428.207.485
2023Q42024-03-13-0.020-0.040-0.1647.196.945
2023Q32023-11-08-0.030-0.050-0.0307.007.935
2023Q22023-08-09-0.050-0.057-0.0556.946.903
2023Q12023-05-04-0.050-0.050-0.0537.397.443
2022Q42023-03-08-0.040-0.057-0.0447.347.383

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2018FY0.0200.0300.02317.3517.54
2019FY0.1290.0650.01423.1622.33
2020FY0.0310.025-0.02924.1824.80
2021FY-0.100-0.104-0.10323.4923.06
2022FY-0.190-0.197-0.19327.9027.91
2023FY-0.130-0.180-0.30128.5228.26
2024FY-0.130-0.106-0.13333.6533.70
2025FY-0.060-0.066-0.06041.1341.03
2026FY--0.022--48.16
2027FY-0.026--56.31
2028FY-0.120--64.87

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-1140012.9412.7013.17
2026Q4S2026-11-1040012.9212.7013.17
2026Q4S2026-10-2040012.9312.7013.20
2026Q4S2026-08-2740112.9312.7013.20
2026Q4S2026-08-2050212.8812.7013.20
2026Q4S2026-08-1150212.8812.7013.17
2026Q4S2026-08-0650212.8812.7013.17
2026Q4S2026-07-2150013.0112.8013.23
2026Q4S2026-05-2750113.0112.8013.23
2026Q4S2026-05-0751213.0112.8013.23
2026Q4S2026-03-3151113.0812.8013.35
2026Q4S2026-03-1352113.0812.8013.35
2026Q4S2026-01-3051013.1412.6013.50
2026Q4S2026-01-2951013.1412.6013.50

Estimate history

EPS, annual0.030.0230.014-0.029-0.103-0.193-0.301-0.133-0.057-0.0182
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.035-0.034-0.025-0.005-0.017-0.011-0.0170.0050.005
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual15.97717.35423.16324.17623.4927.89628.51833.64641.12746.27
Period201720182019202020212022202320242025TTM
Sales, quarterly8.188.8399.63510.19510.40210.89511.76512.04511.567
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual37.99438.19639.50343.2644.62445.44145.66945.95746.3746.375
Period201720182019202020212022202320242025MRQ
Shares, quarterly45.83745.95746.14146.23546.29346.3746.13346.14946.375
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue46.2741.1333.6528.5227.9023.4924.1823.1617.35
Cost of Goods Sold Incl. D&A17.6316.3313.2012.6813.1110.189.668.656.85
Gross Profit28.6424.7920.4415.8414.7813.3114.5214.5110.50
Selling, General and Administrative Excl. Other29.2227.7726.8926.1125.5620.3413.2310.519.34
Research and Development4.814.395.265.744.962.471.300.740.24
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-0.58-2.97-6.45-10.27-10.78-7.031.294.001.16
Interest Expense--------0.00
Unusual Expense0.020.000.000.00-0.002.543.42-
Net Income Before Taxes-0.79-2.62-6.06-9.77-10.68-6.36-1.190.701.18
Income Taxes0.030.020.003.97-2.01-1.800.020.130.27
Consolidated Net Income-0.82-2.64-6.07-13.74-8.66-4.56-1.210.560.91
Net Income From Continuing Operations-0.82-2.64-6.07-13.74-8.66-4.56-1.210.560.91
Net Income-0.82-2.64-6.07-13.74-8.66-4.56-1.210.560.91
EPS (Recurring)-0.02-0.06-0.13-0.30-0.19-0.100.010.080.02
EPS (Basic, Before Extraordinaries)-0.02-0.06-0.13-0.30-0.19-0.10-0.030.010.02
EPS (Diluted)-0.02-0.06-0.13-0.30-0.19-0.10-0.030.010.02
EBITDA0.22-2.16-5.56-9.40-10.19-6.571.714.341.47
Non-Operating Income (Expense)-0.200.360.380.500.110.670.060.110.01
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.001.741.211.531.732.221.010.880.20
Price To Earnings Ratio-------456.6470.82
Price To Sales Ratio2.966.525.243.935.765.6710.4411.013.70
Gross Margin61.9060.2860.7655.5452.9956.6560.0562.6660.51
Operating Margin-1.24-7.23-19.16-36.01-38.65-29.935.3317.286.71
Net Margin-1.78-6.41-18.03-48.18-31.05-19.42-5.012.445.25
Shares Outstanding46.3846.3745.9645.6745.4444.6243.2639.5038.20
Market Capitalization179.61179.61176.47112.12161.65133.68264.54257.9563.06

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue11.5712.0511.7610.9010.4010.199.648.84
Cost of Goods Sold Incl. D&A4.234.414.734.264.343.933.813.49
Gross Profit7.347.647.036.646.066.275.835.35
Selling, General and Administrative Excl. Other7.137.017.907.196.936.587.076.94
Research and Development1.281.071.321.140.931.191.111.11
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income0.210.63-0.86-0.55-0.87-0.31-1.25-1.59
Unusual Expense0.020.000.000.000.000.000.000.00
Net Income Before Taxes0.240.26-0.81-0.48-0.78-0.19-1.17-1.56
Income Taxes0.020.010.000.00-0.000.020.000.00
Consolidated Net Income0.220.25-0.81-0.49-0.78-0.21-1.17-1.56
Net Income From Continuing Operations0.220.25-0.81-0.49-0.78-0.21-1.17-1.56
Net Income0.220.25-0.81-0.49-0.78-0.21-1.17-1.56
EPS (Recurring)0.000.01-0.02-0.01-0.02-0.00-0.03-0.03
EPS (Basic, Before Extraordinaries)0.000.01-0.02-0.01-0.02-0.00-0.03-0.03
EPS (Diluted)0.000.01-0.02-0.01-0.02-0.00-0.03-0.03
EBITDA0.420.84-0.67-0.37-0.66-0.10-1.03-1.38
Non-Operating Income (Expense)0.05-0.370.060.060.090.120.080.03
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.230.310.331.130.200.130.360.09
Price To Sales Ratio2.964.614.636.544.534.493.335.25
Gross Margin63.4263.3959.7960.9358.2661.4760.5060.55
Operating Margin1.815.21-7.35-5.02-8.34-3.07-12.92-17.98
Net Margin1.892.10-6.86-4.47-7.48-2.03-12.10-17.66
Shares Outstanding46.3846.1546.1346.3746.2946.2346.1445.96
Market Capitalization179.61192.92200.32269.13177.08165.18116.73176.47

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments8.879.5811.4817.4125.3327.325.875.264.24
Short Term Receivables6.536.004.074.534.312.573.231.431.86
Inventories3.682.803.486.406.116.832.392.101.66
Other Current Assets0.910.751.221.461.570.810.390.250.17
Total Current Assets19.9919.1320.2629.8037.3237.5311.889.037.93
Net Property, Plant & Equipment7.437.267.357.671.201.400.990.860.84
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Long-Term Note Receivable--------0.00
Intangible Assets0.680.730.750.790.810.840.810.630.48
Deferred Tax Assets1.361.240.003.971.940.130.190.00-
Other Assets0.100.100.100.100.020.020.020.020.03
Total Assets29.5628.4528.4642.3341.2939.9213.8810.559.28
Short Term Debt Incl. Current Port. of LT Debt0.540.790.790.880.600.140.140.000.00
Accounts Payable2.271.650.982.391.230.620.570.450.45
Income Tax Payable-----0.000.20--
Other Current Liabilities5.394.762.693.692.962.901.491.131.13
Total Current Liabilities8.197.204.456.964.793.672.411.581.59
Long Term Debt2.963.203.654.050.000.100.240.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities1.361.24-----0.000.02
Other Liabilities0.000.000.000.000.000.000.000.000.00
Total Liabilities12.5111.648.1111.014.793.762.651.581.61
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity17.0516.8120.3531.3336.5036.1611.248.967.67
Total Shareholders Equity17.0516.8120.3531.3336.5036.1611.248.967.67
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity17.0516.8120.3531.3336.5036.1611.248.967.67
Total Liabilities & Stockholders Equity29.5628.4528.4642.3341.2939.9213.8810.559.28
Book Value Per Share0.370.370.450.690.820.840.280.230.20
Tangible Book Value Per Share0.350.350.430.670.800.820.260.220.19
Full-Time Employees7380828577101717673
Price to Book Ratio9.309.954.084.973.677.2022.967.036.46
Return on Assets-9.09-21.32-38.82-20.71-11.24-4.514.629.19-
Return on Equity-15.58-32.64-53.18-25.54-12.56-5.115.5910.95-
Return on Invested Capital-13.19-30.31-57.24-24.48-12.50-3.344.9210.1614.16
Quick Ratio1.992.273.773.366.518.373.954.373.95
Current Ratio2.442.664.554.287.7910.244.945.705.00

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-0.82-2.64-6.07-13.74-8.66-4.56-1.210.560.91
Depreciation0.800.810.890.870.590.460.420.340.31
Other Funds (Non Cash)3.362.612.888.813.292.712.921.150.30
Funds from Operations3.330.78-2.29-6.10-6.81-3.212.191.871.50
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-2.89-0.321.971.201.40-1.11-2.93-1.55-0.02
Income Taxes Payable-----0.00-0.200.19-
Cash from Operating Activities0.440.46-0.32-4.89-5.40-4.32-0.740.321.48
Capital Expenditures-1.63-0.96-1.34-0.81-2.80-0.38-1.06-0.43-0.48
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.010.010.010.000.000.010.030.220.01
Purchase or Sale of Investments0.000.000.000.000.000.000.001.52-1.25
Purchase of Investments0.000.000.000.000.000.000.000.00-1.50
Sale Or Maturity of Investments0.000.000.000.000.000.000.001.520.25
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-1.62-0.95-1.33-0.81-2.80-0.37-1.041.31-1.73
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock0.290.190.000.000.412.2023.230.510.05
Repurchase of Common Pref Stock0.000.000.000.000.000.00-3.50-0.000.00
Sale of Common Pref Stock0.290.190.000.000.412.2026.730.510.05
Proceedsfrom Stock Options0.000.000.000.000.412.2026.730.510.05
Issuance or Reduction of Debt, Net-0.13-0.38-0.15-0.19-0.130.51-0.01-0.000.00
Change in Long Term Debt-0.13-0.38-0.15-0.19-0.130.51-0.01-0.000.00
Issuance of Long Term Debt0.400.410.490.570.780.924.980.000.00
Reduction of Long Term Debt-0.54-0.79-0.64-0.75-0.91-0.42-4.98-0.000.00
Net Financing Active Other Cash Flow-0.08-0.03-0.10-0.030.000.000.000.00-0.04
Other Financing Activities Uses-0.08-0.03-0.10-0.03---0.00-0.04
Cash from Financing Activities0.08-0.22-0.25-0.220.282.7123.220.500.01
Net Change in Cash-1.10-0.71-1.90-5.93-7.93-1.9821.442.13-0.24
Free Cash Flow-0.39-0.47-1.62-5.68-8.17-4.67-1.660.121.18
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow-------2,136.2754.30
Deferred Taxes & Investment Tax Credit-0.000.00-2.04-2.03-1.820.06-0.19-0.02

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments7.368.298.778.878.468.05
Short Term Receivables6.986.096.326.535.525.09
Inventories4.694.514.483.684.413.95
Other Current Assets1.100.621.030.911.030.49
Total Current Assets20.1419.5120.5919.9919.4217.58
Net Property, Plant & Equipment6.666.697.197.436.907.14
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets1.891.660.710.680.680.70
Deferred Tax Assets---1.36--
Other Assets0.100.100.100.100.100.10
Total Assets28.7827.9628.5929.5627.1025.52
Short Term Debt Incl. Current Port. of LT Debt0.900.580.550.540.870.53
Accounts Payable1.882.912.642.271.871.09
Other Current Liabilities4.013.695.675.395.094.43
Total Current Liabilities6.797.188.858.197.836.05
Long Term Debt2.602.732.822.962.802.94
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---1.36--
Other Liabilities0.000.000.000.000.000.00
Total Liabilities9.399.9111.6712.5110.648.99
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity19.4018.0516.9217.0516.4616.53
Total Shareholders Equity19.4018.0516.9217.0516.4616.53
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity19.4018.0516.9217.0516.4616.53
Total Liabilities & Stockholders Equity28.7827.9628.5929.5627.1025.52
Book Value Per Share0.420.390.370.370.360.36
Tangible Book Value Per Share0.380.360.350.350.340.34
Full-Time Employees---73--
Price to Book Ratio9.3011.4511.7516.3410.7210.11
Return on Assets-2.95-6.80-8.17-9.09-13.62-17.10
Return on Equity-4.59-10.52-13.70-15.58-21.71-25.63
Return on Invested Capital0.991.21-4.09-2.43-4.04-1.06
Quick Ratio2.272.091.821.991.922.25
Current Ratio2.972.722.332.442.482.91

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income0.220.25-0.81-0.49-0.78-0.21
Depreciation0.210.210.200.180.200.21
Other Funds (Non Cash)0.950.860.680.870.630.42
Funds from Operations1.371.320.070.560.050.42
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-2.26-1.11-0.060.530.01-0.88
Cash from Operating Activities-0.880.220.011.090.07-0.46
Capital Expenditures-0.53-0.58-0.09-0.43-0.05-0.03
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.010.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.53-0.58-0.09-0.42-0.05-0.03
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.200.000.000.100.090.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.200.000.000.100.090.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.30-0.04-0.03-0.360.31-0.16
Change in Long Term Debt0.30-0.04-0.03-0.360.31-0.16
Issuance of Long Term Debt0.400.000.000.000.410.00
Reduction of Long Term Debt-0.11-0.04-0.03-0.36-0.10-0.16
Net Financing Active Other Cash Flow0.00-0.080.000.000.00-0.03
Other Financing Activities Uses0.00-0.080.000.000.00-0.03
Cash from Financing Activities0.49-0.12-0.03-0.260.40-0.19
Net Change in Cash-0.92-0.48-0.100.410.41-0.68
Free Cash Flow-1.150.11-0.030.690.01-0.49
Price to Free Cash Flow-267.761,117.10---

Revenue breakdown

Surgical & Medical Instruments & Apparatus2024: 33.65M 2025: 41.13M
Non-US2024: 6.14M 2025: 10.89M
United States2024: 27.51M 2025: 30.24M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-302.00%0.9M43.1M240.06K
2026-10-152.06%0.9M43.1M244.22K
2026-09-302.11%0.9M43.1M225.36K
2026-09-152.29%1.0M43.1M201.50K
2026-08-312.05%0.9M43.1M189.32K
2026-08-141.81%0.8M43.1M174.06K
2026-07-311.86%0.8M43.1M141.68K
2026-07-151.88%0.8M42.9M133.50K
2026-06-301.58%0.7M42.9M143.29K
2026-06-151.73%0.7M42.9M132.19K
2026-05-291.68%0.7M43.1M142.49K
2026-05-151.47%0.6M43.1M156.47K
2026-04-301.44%0.6M42.4M189.66K
2026-04-151.70%0.7M43.3M192.69K
2026-03-311.74%0.8M43.4M190.84K
2026-03-131.47%0.6M43.4M200.76K
2026-02-271.66%0.7M43.3M202.26K
2026-02-132.01%0.9M43.3M206.95K
2026-01-301.69%0.7M43.7M169.26K
2026-01-151.55%0.7M43.7M157.51K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.500.004.901.400.00020.0010.000.929-0.0110.001
call5.000.002.000.031.32930.0074.000.134-0.0100.001
call7.500.004.900.002.6270.000.000.081-0.0140.001
put2.500.000.050.052.2001.000.00-0.072-0.0100.001
put5.000.005.002.054.74212.000.00-0.866-0.0090.001
put7.502.206.000.0013.7840.000.00-0.919-0.0130.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-108-KCurrent report2026-11-10SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-09-08SEC
2026-08-148-KCurrent report2026-08-13SEC
2026-08-064Statement of changes in beneficial ownership of securities2026-07-28SEC
2026-08-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-058-KCurrent report2026-08-05SEC
2026-08-03144Filing for proposed sale of securities under Rule 144.SEC
2026-07-29SCHEDULE 13GSEC
2026-07-134/A2026-07-01SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-06-308-KCurrent report2026-06-24SEC
2026-06-154Statement of changes in beneficial ownership of securities2026-06-11SEC
2026-05-218-KCurrent report2026-05-19SEC
2026-05-204Statement of changes in beneficial ownership of securities2026-05-18SEC
2026-05-204/A2026-05-15SEC
2026-05-204Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-14SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-09101.12K100
2026-080000
2026-070000
2026-0649.28K100
2026-0564.86K400
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
First Light Asset Management, LLC7.38%
Topline Capital Management, LLC7.35%
BlackRock, Inc.5.72%
VANGUARD CAPITAL MANAGEMENT LLC3.96%
GEODE CAPITAL MANAGEMENT, LLC2.25%
Meros Investment Management, LP1.65%
Simcoe Capital LLC1.55%
Lionhunter Capital Management, LLC1.51%
STATE STREET CORP1.41%
Archon Capital Management LLC1.40%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.73%
iShares Russell 2000 ETF2.48%
VANGUARD EXTENDED MARKET INDEX FUND1.13%
Fidelity Small Cap Index Fund1.06%
iShares Russell 2000 Growth ETF0.92%
VANGUARD RUSSELL 2000 INDEX FUND0.56%
Fidelity Extended Market Index Fund0.51%
iShares Micro-Cap ETF0.33%
SIMT Tax-Managed Small/Mid Cap Fund0.28%
Schwab Small-Cap Index Fund0.25%

OakChart. KRMD. Cached 15 minutes.